PanGen Biotech Overview
- Year Founded
-
2010
- Status
-
Public
- Employees
-
75
- Stock Symbol
-
222110
- Investments
-
1
- Share Price
-
$3.00
- (As of Friday Closing)
PanGen Biotech General Information
Description
Pangen Biotech Inc is a biotechnology company. The company is engaged in the production and sales of biosimilar EPO drugs, contract manufacturing (CMO), and development technology transfer service (CDO) business for biopharmaceuticals, including non-clinical and clinical samples, and biopharmaceutical development business.
Contact Information
Website
www.pangen.comCorporate Office
- Woncheon-dong, 4 Floor Innoplex 2-dong 306
- Sinwon-ro, Yeongtong-gu
- Suwon, Gyeonggi 16675
- South Korea
Corporate Office
- Woncheon-dong, 4 Floor Innoplex 2-dong 306
- Sinwon-ro, Yeongtong-gu
- Suwon, Gyeonggi 16675
- South Korea
PanGen Biotech Timeline
PanGen Biotech Stock Performance
As of 13-Nov-2026, PanGen Biotech’s stock price is $3.00. Its current market cap is $40.6M with 13.5M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.00 | $2.99 | $2.59 - $5.77 | $40.6M | 13.5M | 6.56K | $0.06 |
PanGen Biotech Financials Summary
As of 30-Jun-2026, PanGen Biotech has a trailing 12-month revenue of $9.8M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 34,723 | 43,996 | 46,314 | 57,657 |
| Revenue | 9,769 | 9,428 | 10,754 | 5,595 |
| EBITDA | 1,650 | 2,286 | 1,912 | (2,039) |
| Net Income | 780 | 1,441 | 692 | (3,433) |
| Total Assets | 21,567 | 22,708 | 20,737 | 16,095 |
| Total Debt | 5 | 668 | 556 | 1,566 |
PanGen Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
PanGen Biotech Patents
PanGen Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260014088-A1 | Lipid nanoparticles for protein delivery | Pending | 15-Jul-2022 | ||
| WO-2024014928-A1 | Lipid nanoparticles for protein delivery | Inactive | 15-Jul-2022 | ||
| EP-4186492-A1 | Ophthalmic liquid composition | Active | 24-Jul-2020 | ||
| EP-4186492-A4 | Ophthalmic liquid composition | Active | 24-Jul-2020 | ||
| EP-4186492-B1 | Ophthalmic liquid composition | Active | 24-Jul-2020 | A61K9/08 |
PanGen Biotech Signals
PanGen Biotech Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
PanGen Biotech Investments (1)
PanGen Biotech’s most recent deal was a Joint Venture with Biosimilar Production Facility (Duopharma Biotech Berhad / PanGen Biotech / VentureTECH Sdn Bhd). The deal was made on 17-Jul-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Biosimilar Production Facility (Duopharma Biotech Berhad / PanGen Biotech / VentureTECH Sdn Bhd) | 17-Jul-2020 | Joint Venture | Pharmaceuticals |
PanGen Biotech ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
PanGen Biotech FAQs
-
When was PanGen Biotech founded?
PanGen Biotech was founded in 2010.
-
Where is PanGen Biotech headquartered?
PanGen Biotech is headquartered in Suwon, South Korea.
-
What is the size of PanGen Biotech?
PanGen Biotech has 75 total employees.
-
What industry is PanGen Biotech in?
PanGen Biotech’s primary industry is Pharmaceuticals.
-
Is PanGen Biotech a private or public company?
PanGen Biotech is a Public company.
-
What is PanGen Biotech’s stock symbol?
The ticker symbol for PanGen Biotech is 222110.
-
What is the current stock price of PanGen Biotech?
As of 13-Nov-2026 the stock price of PanGen Biotech is $3.00.
-
What is the current market cap of PanGen Biotech?
The current market capitalization of PanGen Biotech is $40.6M.
-
What is PanGen Biotech’s current revenue?
The trailing twelve month revenue for PanGen Biotech is $9.8M.
-
What is PanGen Biotech’s annual earnings per share (EPS)?
PanGen Biotech’s EPS for 12 months was $0.06.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process